This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
D

ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Current and Novel IO Approaches"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING David Braun
By 2024 ASCO® Annual Meeting Insights Hub FEATURING David Braun
184 views
June 7, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GU Videos

21:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

Feat. E. Efstathiou
10:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…

Feat. K. Mittal
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
View All

Related Content

AUTOPLAY
Advanced Prostate Cancer Consensus Conference (APCCC)

APCCC 2026

Fri, Feb 27, 2026
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
10:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…

Feat. K. Mittal
03:05
Benjamin L. Maughan

Testosterone Suppression and Recovery in Patients With Advanced Pros…

06:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence f…

Feat. J. Hafron
10:19
University of Colorado Cancer Center

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Feat. T. Flaig
22:07
Weill Cornell Medicine Oncology & Hematology

Urothelial Carcinoma: New Developments

Feat. C. Sternberg
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
06:58
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…

Feat. M. Zarba
09:40
UCSF School of Medicine

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

Feat. V. Koshkin
13:46
David McDermott

Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data

22:03
Dana-Farber Cancer Institute

RCC Highlights From ASCO® GU 2024

Feat. W. Xu, T. Choueiri
09:00
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiratero…

Feat. C. Kyriakopoulos
17:33
Benjamin Garmezy

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …

06:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcin…

Feat. E. Jonasch